Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan
BISHKEK, Kyrgyzstan, April 3, 2024 /PRNewswire/ -- The International Medical Congress of the SCO countries was held on 27-29 March in Bishkek, Kyrgyzstan, under the theme "Innovations and technologies in the development of cardiology and non-communicable diseases in the countries of the Shanghai Cooperation Organization". Alymkadyr Beishenaliev, Minister of Health of the Kyrgyz Republic, Janesh Kane, Deputy Secretary General...
Bloomage ‘YunZhong (In Cloud) Public Welfare’ Campaign: A 14-Year Journey of Cultural Preservation and Sustainability
PARSIPPANY, N.J., Oct. 22, 2024 /PRNewswire/ -- Bloomage, a global leader in the research, development, production, and sale of hyaluronic acid and other bioactive substances, continues to showcase its leadership in Environmental, Social, and Governance (ESG) initiatives. The company's YunZhong (In Cloud) Public Welfare campaign, which has been held for over 14 years, focuses on preserving fading cultures alongside...
ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting
SUZHOU, China, and ROCKVILLE, Md., Nov. 4, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the updated results from three studies of the company's novel drug candidate, olverembatinib (HQP1351), have been selected for oral...
Inaugural Process Innovation Asia Pacific to Drive Industry Transformation for South-East Asia’s Chemicals and Pharmaceuticals
SINGAPORE, Aug. 22, 2024 /PRNewswire/ -- Organised by Constellar, in partnership with DECHEMA Ausstellungs-GmbH (DECHEMA Exhibitions), the inaugural Process Innovation Asia Pacific - Powered by ACHEMA (PIA) will be held from 19 to 21 November 2024 at Singapore EXPO. The most comprehensive Process Technology show for South-East Asia, PIA 2024 will address...
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics® technology. PRISM BioLab receives upfront payments and up to $660 million in total milestones, plus royalties on net sales. TOKYO, Nov. 29, 2023 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM"), a...
111, Inc. Becomes First Online Retail Platform for BGI’s SARS-CoV-2 Virus Antigen Detection Kits
SHANGHAI, March 14, 2022 /PRNewswire/ -- On March 14, 2022, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company signed a strategic cooperation agreement with Shenzhen BGI Co., Ltd. (SZ: 300676) under which BGI will supply its SARS-CoV-2 Virus Antigen Detection Kits (Immunofluorescence Chromatography) across China via 111's online pharmacy, 1 Pharmacy, in...
Moyom Biotechnology Announces Strategic Partnership with WPP Group to Elevate Aphranel’s “Poetics of Time” Brand Positioning
SHANGHAI, Jan. 26, 2026 /PRNewswire/ -- Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global communications and creative networks. The partnership is centered on the "Poetics of Time" brand framework and will focus on the long-term evolution of Aphranel's global brand communications. Moyom Biotechnology Announces Strategic Partnership with WPP Group ...
Resource for journalists around the world on COVID-19 vaccines
covidvaccinehub.org (https://covidvaccinehub.org/) If you're a fact checker or a journalist, we're here to help you find the information and experts you need for your story. SYDNEY, Nov. 22, 2021 /PRNewswire/ -- The COVID-19 Vaccine Media Hub (https://covidvaccinehub.org/) is a dedicated global resource for journalists and fact checkers wanting access to evidence-based information on COVID-19 vaccines with material available in...
Bloomage Ranks on World Brand Lab’s China 500 Most Valuable Brands List
PARSIPPANY, N.J., July 2, 2024 /PRNewswire/ -- Bloomage has once again ranked on the "China's 500 Most Valuable Brands" list by World Brand Lab, a premier global brand value evaluation agency. This milestone not only affirms the strength of Bloomage's brand but also recognizes its long-term commitment to sustainable innovation. For 20 years, The World Brand...
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND
SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its IND application of its self-developed 9MW3811 injection for tumor and pulmonary fibrosis has been approved by the Therapeutic Goods Administration (TGA) in Australia. 9MW3811 is the first IL-11 targeting monoclonal antibody approved to clinical study at present....
